|
V.S. Nikiforov
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
|
№13 / 2022
|
|
O.A. Polyakova (1), A.A. Chochua (1), O.V. Golovina (1), E.V. Mironova (2), O.D. Ostroumova (1)
Possibilities of using trimetazidine in the treatment of patients with ischemic heart disease and chronic heart failure
|
№13 / 2021
|
|
S.G. Kanorsky, N.V. Smolenskaya
TRIPLE COMBINATIONS OF ANTIANGINAL PREPARATIONS IN THE TREATMENT OF STABLE EFFORT STENOCARDIA IN ELDERLY AND SENILE PATIENTS
|
№18 / 2017
|
|
N.P. Lyamina (1), A.V. Nalivaeva (1), A.V. Vlasova (2), E.A. Kulikova (3)
PREPARATIONS WITH METABOLIC ACTION (ANGIOZIL RETARD, IDRINOL) IN THE PREVENTION AND TREATMENT OF CORONARY SYNDROMES IN OUTPATIENT SETTINGS
|
№20 / 2015
|
|
E.V. Privalova
MODERN LOOK AT ANTIANGINAL THERAPY OF PATIENTS WITH CORONARY ARTERY DISEASE
|
№13 / 2015
|
|
M.V. Novikova (1), M.G. Glezer (1, 2)
EFFECT OF TREATMENT WITH TRIMETAZIDINE ON INDICATORS OF EXERCISE TOLERANCE AND QUALITY OF LIFE OF PATIENTS WITH STABLE ANGINA RECEIVING OPTIMAL DRUG THERAPY
|
№9 / 2014
|
|
I.R. Gaysin (1), A.S. Gazimzyanova (1,2), T.V. Sokolova (2), N.I. Maksimov (1), A.A. Galimova (2), M.A. Voronova (2), E.A. Chernykh (2), I.R. Poyarkina (2)
TRIMETAZIDINE IS EFFECTIVE IN REHABILITATION OF PATIENTS AFTER HEART VALVE REPLACEMENT: THE RESULTS OF 1-YEAR RANDOMIZED CONTROLLED STUDY
|
№6 / 2014
|
|
M.G. Gleser (1, 2), E.I. Astashkin (1), M.V. Novikova (2)
TREATMENT OF STABLE ANGINA: CURRENT STATE OF PROBLEM
|
№18 / 2013
|
|
A.M. Shilov
PLACE OF DRUGS WITH METABOLIC ACTION (TRIMEKTAL MR) IN THE TREATMENT OF ISCHEMIC SYNDROMES
|
№13 / 2013
|
|
O.A. Mubarakshina , M.N. Somova
MODERN APPROACHES TO THE METABOLIC PROTECTION OF MYOCARDIUM
|
№13 / 2013
|
|
D.A. Napalkov, A.V.Zhilenko
CYTOPROTECTION IN CARDIOLOGY: MYTH OR REALITY?
|
№6 / 2013
|
Русский
